m.limatoxi.com >> EN >> Pharmaceutical News -

Home Page

News

Statistics

API Review

Formulation

Monthly

Im&Ex report

All Information



	Keyword:

E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463

　　Our services:

China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information

Conference on ...

Information Release...

Internationalization&nbs...

Welcome to Pro...

Healthoo.com Carbap...

APIs Innovation&nbs...

China Import Export Statistics Report In...

API Export Price by ...

Tylosin Bulk Drug Export&...

China Monthly Export Stat...

Your position:m.limatoxi.com >> EN >> Pharmaceutical News

Guangji slightly raised Vitamin B2 price	2012-02-15
Xieli's Irinotecan, Troxerutin and Rutin passed EU-GMP	2012-02-14
Jiangxi Yongfeng plans to build Vitamin D2 project	2012-02-14
Zhejiang Medicine stopped providing Vitamin A & E price	2012-02-13
NHU stopped providing Vitamin E quoted price	2012-02-09
Shanghai Pharmaceutical decided to buy Changzhou Kangli	2012-02-06
Xinfa's Vitamin A and E projects planned into production	2012-02-03
China aims to form big-size pharmaceutical enterprise	2012-02-02
Guangji Pharma resumes Vitamin B2 production	2012-02-01
NCPC Huamin's Cephalexin got import certificate in India	2012-01-31
NBP (Butylphthalide) sale reaches 500 Mn Yuan in 2011	2012-01-29
Most potential Chinese listed (medical) companies by Forbes	2012-01-29
Reimbursement by disease types to widely boost in China	2012-01-20
SFDA approved Novartis's eye drug Lucentis	2012-01-19
Shandong Xinhua bought a penicillins producer	2012-01-18
Chinese pharmaceuticals and medical equipment export to surge	2012-01-18
Anhui Hechen plans to build Doripenem project	2012-01-16
Sinopharm business revenue over 110 billion Yuan in 2011	2012-01-16
Fangtong plans to expand Saponin capacity	2012-01-16
China approves first hepatitis E vaccine in the world	2012-01-13
Jiangxi Tonglian's Amoxicillin project going smoothly	2012-01-13
Sinovac begins hand, foot & mouth disease EV71 vaccine phase III trial	2012-01-13
Pfizer launched Taige (tigecycline) in China	2012-01-12
NHU stoppted providing Vitamin D3 price	2012-01-11
A Thailand company purchases Zhongrun's Amoxicillin	2012-01-10
Ukraine client checked CSPC's Ceftriaxone and Cefazolin	2012-01-10
Sales revenues of NCPC and CSPC in 2011	2012-01-10
Iguratimod launched in China for RA	2012-01-09
Brother planned to build 10,000 ton Nicotinamide project	2012-01-09
Export license administration continued for Penicillin G, Vitamin C	2012-01-06
AstraZeneca started to build manufacturing facility in Taizhou	2012-01-05
Export value of China's APIs up 35% Jan. to Oct. 2011	2012-01-04

共4532个页次:91/142页 32个/页首页上一页下一页尾页转到：

Our Advantages of Reports

①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark

Purchase Flow of Reports

①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice

Bank account

①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG

Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463

map